Chemokine antagonism in chronic hepatitis C virus infection
Authors:
Open Access
- 4 January 2011
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 121 (1) , 25-27
Abstract
Immune responses to hepatitis C virus (HCV) fail to clear the virus in most individuals. Why patients who are less likely to clear HCV infection have high plasma levels of CXCL10 (also known as IP-10), a chemokine that directs T cells to sites of infection, has long been unclear. In this issue of the JCI, Casrouge and colleagues shed light on this paradox by showing that CXCL10 in the plasma of many HCV patients is enzymatically processed to produce a CXCL10 receptor antagonist. These findings introduce a role for chemokine antagonism during HCV infection and unveil new avenues for improved HCV diagnosis and therapy.Keywords
This publication has 23 references indexed in Scilit:
- Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCVJournal of Clinical Investigation, 2011
- Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistenceJournal of Clinical Investigation, 2009
- Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis CHepatology, 2008
- Antiviral therapy: chronic hepatitis CJournal of Viral Hepatitis, 2007
- Altered expression of glucagon‐like peptide‐1 and dipeptidyl peptidase IV in patients with HCV‐related glucose intoleranceJournal of Gastroenterology and Hepatology, 2007
- Interferon (IFN)–γ–Inducible Protein–10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN‐α2a and Ribavirin for Chronic Hepatitis C Virus InfectionThe Journal of Infectious Diseases, 2006
- Insulin resistance and steatosis in hepatitis C virus infectionGut, 2005
- The Natural History of Hepatitis CSeminars in Liver Disease, 2004
- Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic propertiesBlood, 2001
- The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.Journal of Clinical Investigation, 1998